<DOC>
	<DOCNO>NCT01161082</DOCNO>
	<brief_summary>This study test safety , tolerability , bioeffects ( body react drug ) REGN727 compare placebo ( inactive substance contains medicine ) hyperlipidemic patient without atorvastatin therapy . The study drug placebo administer subcutaneous injection clinic . There total 2 3 study drug injection 16 clinic visit , include 3 overnight stay ( study duration 148 day , include screen period ) . Patients atorvastatin take daily dose morning duration study . Patients monitor study staff side effect body 's response study drug . Vital sign ( blood pressure , temperature , breathe heart rate ) check , blood urine sample collect visit .</brief_summary>
	<brief_title>Ascending Multi-dose Study REGN727 ( SAR236553 ) With Without Concomitant Atorvastatin</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Inclusion Criteria Men woman elevate cholesterol stable dos atorvastatin 1040mg/day regimen Body mass index 18.0 35.0 kg/m2 , inclusive For woman childbearing potential , negative serum pregnancy test screen visit negative urine pregnancy test day 2 day 1 For men woman childbearing potential , willingness utilize adequate contraception become pregnant ( partner [ ] become pregnant ) full duration study Willing , commit able return clinic visit complete studyrelated procedure Able read , able sign inform consent form History MI , ACS , Angina , Stroke , peripheral vascular disease , cardiac revascularization Pregnant breastfeed woman Blood donation volume within 1 month prior administration study drug Congestive heart failure Consumption great 1 quart grapefruit juice per day Previous exposure therapeutic investigational biological agent within 30 day screen History alcohol drug abuse within one year screen visit The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>